PRTT Protect Pharmaceutical Corp

Protect Pharmaceutical Corporation Joins Tobit Consortium

Protect Pharmaceutical Corporation Joins Tobit Consortium

LAS VEGAS, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces that it has become a Founding Member of the Tobit Consortium.

Protect Pharmaceutical announced in September that it along with several other businesses entered into an agreement that will result in the creation of the Property Tobit Exchange business model and that it intends to change its name following the acquisition of certain strategic assets from consortium members to the Property Tobit Exchange Corporation.

The Tobit Consortium will allow PRTT access to hundreds of cryptocurrency experts and hundreds of thousands of cryptocurrency users, merchants, service providers, and investors. The company believes this association with the Tobit Consortium will be instrumental in rapidly creating PRTT’s ability to tokenize real estate and accelerating its plan to build a decentralized real estate exchange platform. The Tobit Consortium’s mission is to promote the use of the ERC -20 crypto utility token Tobit for a variety of industries and to create the world’s first truly globally utility token.  The Tobit Consortium is engaging experts and companies from around the world in order to ensure mass adaptation of it’s token due to its practical utility for non-technical users. “I created the Tobit Consortium to organize the large community of people, companies, and organizations interested in using the Tobit token for various community empowerment projects around the world. PRTT’s real estate tokenization project is an excellent fit for our community and we are excited to assist in the use of the Tobit for this application,” stated Damien Ramos Founder of Tobit Consortium and creator of the Tobit token.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC including the Current Reports on Form 8-K and the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. 

For more information contact:
Protect Pharmaceutical Corporation
954-866-3726
EN
02/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Protect Pharmaceutical Corp

 PRESS RELEASE

Ali Yildiz December 29, 2023 Letter to the Shareholders of Protect Pha...

Ali Yildiz December 29, 2023 Letter to the Shareholders of Protect Pharmaceutical Corp. Istanbul, Turkey, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Ali Yildiz Addresses shareholders of the company. We wanted to update shareholders in regards to the progress on our PCAOB Audit. We had a small delay that originated from the auditor needing physical access to a secure facility that houses customs products. We believe the delay will be minimal and are still on track to finalize our audit within the next week to two weeks. We apologize for the unforeseen dela...

 PRESS RELEASE

Ali Yildiz December 22, 2023 Letter to the Shareholders of Protect Pha...

Ali Yildiz December 22, 2023 Letter to the Shareholders of Protect Pharmaceutical Corp. Istanbul, Turkey, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Ali Yildiz Addresses shareholders of the company. As we stated last week we are in the final stages of our PCAOB audit and expect its completion very soon. We have now responded to the open items to the auditor. We expect to receive the finalized audit report very soon and feel we can still meet our goal of completion before year end. As we end the year we are optimistic and believe that the company has accom...

 PRESS RELEASE

Protect Pharmaceutical Corp. CEO Provides Shareholder Update

Protect Pharmaceutical Corp. CEO Provides Shareholder Update Istanbul, Turkey, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp. CEO Ali Yildiz Provides Shareholder Update. As CEO of PRTT I wanted to update shareholders on current progress within the company. We posted our largest quarter for revenues for the second consecutive quarter. Our growth strategy is working and we recently announced the acquisition of Bosfor Export. This is one of several acquisition targets and we plan to continue to grow and expand not only our curr...

 PRESS RELEASE

Protect Pharmaceutical Corp. Acquires Bosfor Export

Protect Pharmaceutical Corp. Acquires Bosfor Export Istanbul, Turkey, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC: PRTT” is pleased to announce the acquisition of Bosfor Export. This strategic move has been financed through the issuance of 2,000,000 restricted shares, representing 100% ownership of Bosfor Export. Bosfor Export, known for its robust fruit wholesaling operations in Istanbul, currently achieves an annual revenue of approximately $28 million USD. With this acquisition, PRTT's management is optimistic about significantly increasing revenues by leveragi...

 PRESS RELEASE

Protect Pharmaceutical Corp. CEO Provides Shareholder Update

Protect Pharmaceutical Corp. CEO Provides Shareholder Update Istanbul, Turkey, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp. CEO Ali Yildiz Provides Shareholder Update. As we enter the 4th quarter we feel the company has entered a very pivotal time in our growth strategy. We posted our largest quarter for revenues in the second quarter of 2023 and our expansion goals and strategies are progressing very nicely. For the 6 months ending June 30, 2023 we had 62 million dollars in revenue with an operating profit of over 18 million...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch